These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10805355)

  • 1. The costs of rheumatoid arthritis: an international long-term view.
    Pugner KM; Scott DI; Holmes JW; Hieke K
    Semin Arthritis Rheum; 2000 Apr; 29(5):305-20. PubMed ID: 10805355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
    Hallert E; Husberg M; Jonsson D; Skogh T
    Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
    Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
    Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
    Zhu TY; Tam LS; Li EK
    Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
    Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
    Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey.
    Hamuryudan V; Direskeneli H; Ertenli I; Inanc M; Karaaslan Y; Oksel F; Ozbek S; Pay S; Terzioglu E; Balkan Tezer D; Hacibedel B; Akkoc N
    Clin Exp Rheumatol; 2016; 34(6):1033-1037. PubMed ID: 27749224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
    Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
    Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter cost-of-illness study on rheumatoid arthritis in Italy.
    Leardini G; Salaffi F; Montanelli R; Gerzeli S; Canesi B
    Clin Exp Rheumatol; 2002; 20(4):505-15. PubMed ID: 12175106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era.
    Hsieh PH; Wu O; Geue C; McIntosh E; McInnes IB; Siebert S
    Ann Rheum Dis; 2020 Jun; 79(6):771-777. PubMed ID: 32245893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Pharmacoeconomics; 2005; 23(4):377-93. PubMed ID: 15853437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
    Hu H; Luan L; Yang K; Li SC
    Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding Rheumatoid Arthritis Impact on Life (FRAIL Study): economic burden.
    Miranda LC; Santos H; Ferreira J; Coelho P; Silva C; Saraiva-Ribeiro J;
    Acta Reumatol Port; 2012; 37(2):134-42. PubMed ID: 23149635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline.
    Yelin E; Wanke LA
    Arthritis Rheum; 1999 Jun; 42(6):1209-18. PubMed ID: 10366114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Newhall-Perry K; Law NJ; Ramos B; Sterz M; Wong WK; Bulpitt KJ; Park G; Lee M; Clements P; Paulus HE
    J Rheumatol; 2000 May; 27(5):1156-63. PubMed ID: 10813281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
    Osiri M; Maetzel A; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.
    Bansback NJ; Regier DA; Ara R; Brennan A; Shojania K; Esdaile JM; Anis AH; Marra CA
    Drugs; 2005; 65(4):473-96. PubMed ID: 15733011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey.
    Malhan S; Pay S; Ataman S; Dalkilic E; Dinc A; Erken E; Ertenli I; Ertugrul E; Gogus F; Hamuryudan V; Inanc M; Karaarslan Y; Karadag O; Karakoc Y; Keskin G; Kisacik B; Kiraz S; Oksel F; Oksuz E; Pirildar T; Sari I; Soy M; Senturk T; Taylan A
    Clin Exp Rheumatol; 2012; 30(2):202-7. PubMed ID: 22546069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis.
    Boonen A; Mau W
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S112-7. PubMed ID: 19822056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary].
    Péntek M; Szekanecz Z; Czirják L; Poór G; Rojkovich B; Polgár A; Genti G; Kiss CG; Sándor Z; Májer I; Brodszky V; Gulácsi L
    Orv Hetil; 2008 Apr; 149(16):733-41. PubMed ID: 18426720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs of rheumatoid arthritis.
    Allaire SH; Prashker MJ; Meenan RF
    Pharmacoeconomics; 1994 Dec; 6(6):513-22. PubMed ID: 10155281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.